{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:24:56Z","timestamp":1790745896545,"version":"4.1.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:00:00Z","timestamp":1595635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:00:00Z","timestamp":1595635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K22NS092688"],"award-info":[{"award-number":["K22NS092688"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1R01AG059639"],"award-info":[{"award-number":["1R01AG059639"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARGD-591887"],"award-info":[{"award-number":["AARGD-591887"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cerebral amyloid angiopathy (CAA) is typified by the cerebrovascular deposition of amyloid. The mechanisms underlying the contribution of CAA to neurodegeneration are not currently understood. Although CAA is highly associated with the accumulation of amyloid beta (A\u03b2), other amyloids are known to associate with the vasculature. Alzheimer\u2019s disease (AD) is characterized by parenchymal A\u03b2 deposition, intracellular accumulation of tau, and significant neuroinflammation. CAA increases with age and is present in 85\u201395% of individuals with AD. A substantial amount of research has focused on understanding the connection between parenchymal amyloid and glial activation and neuroinflammation, while associations between vascular amyloid pathology and glial reactivity remain understudied.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Here, we dissect the glial and immune responses associated with early-stage CAA with histological, biochemical, and gene expression analyses in a mouse model of familial Danish dementia (FDD), a neurodegenerative disease characterized by the vascular accumulation of Danish amyloid (ADan). Findings observed in this CAA mouse model were complemented with primary culture assays.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We demonstrate that early-stage CAA is associated with dysregulation in immune response networks and lipid processing, severe astrogliosis with an A1 astrocytic phenotype, and decreased levels of TREM2 with no reactive microgliosis. Our results also indicate how cholesterol accumulation and ApoE are associated with vascular amyloid deposits at the early stages of pathology. We also demonstrate A1 astrocytic mediation of TREM2 and microglia homeostasis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The initial glial response associated with early-stage CAA is characterized by the upregulation of A1 astrocytes without significant microglial reactivity. Gene expression analysis revealed that several AD risk factors involved in immune response and lipid processing may also play a preponderant role in CAA. This study contributes to the increasing evidence that brain cholesterol metabolism, ApoE, and TREM2 signaling are major players in the pathogenesis of AD-related dementias, including CAA. Understanding the basis for possible differential effects of glial response, ApoE, and TREM2 signaling on parenchymal plaques versus vascular amyloid deposits provides important insight for developing future therapeutic interventions.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12974-020-01900-7","type":"journal-article","created":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T11:02:48Z","timestamp":1595674968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy"],"prefix":"10.1186","volume":"17","author":[{"given":"Xavier","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Cisternas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwen","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjian","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunian","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamil","family":"Marambio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5499-3082","authenticated-orcid":false,"given":"Cristian A.","family":"Lasagna-Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,25]]},"reference":[{"issue":"1","key":"1900_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuron.2014.05.041","volume":"83","author":"CM Karch","year":"2014","unstructured":"Karch CM, Cruchaga C, Goate AM. Alzheimer\u2019s disease genetics: from the bench to the clinic. Neuron. 2014;83(1):11\u201326.","journal-title":"Neuron"},{"issue":"5","key":"1900_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrd2896","volume":"9","author":"M Citron","year":"2010","unstructured":"Citron M. Alzheimer\u2019s disease: strategies for disease modification. Nat Rev Drug Discov. 2010;9(5):387\u201398.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"1900_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00401-005-1074-9","volume":"110","author":"J Attems","year":"2005","unstructured":"Attems J. Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. Acta Neuropathol. 2005;110(4):345\u201359.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1900_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3988\/jcn.2011.7.1.1","volume":"7","author":"A Biffi","year":"2011","unstructured":"Biffi A, Greenberg SM. Cerebral amyloid angiopathy: a systematic review. J Clin Neurol. 2011;7(1):1\u20139.","journal-title":"J Clin Neurol"},{"issue":"6","key":"1900_CR5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/ana.22516","volume":"70","author":"A Viswanathan","year":"2011","unstructured":"Viswanathan A, Greenberg SM. Cerebral amyloid angiopathy in the elderly. Ann Neurol. 2011;70(6):871\u201380.","journal-title":"Ann Neurol"},{"issue":"3","key":"1900_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1055\/s-0036-1581993","volume":"36","author":"G Boulouis","year":"2016","unstructured":"Boulouis G, Charidimou A, Greenberg SM. Sporadic cerebral amyloid angiopathy: pathophysiology, neuroimaging features, and clinical implications. Semin Neurol. 2016;36(3):233\u201343.","journal-title":"Semin Neurol"},{"issue":"9","key":"1900_CR7","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/jnen\/59.9.768","volume":"59","author":"D Cadavid","year":"2000","unstructured":"Cadavid D, et al. Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol. 2000;59(9):768\u201373.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"1900_CR8","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1212\/WNL.58.11.1587","volume":"58","author":"SM Greenberg","year":"2002","unstructured":"Greenberg SM. Cerebral amyloid angiopathy and dementia: two amyloids are worse than one. Neurology. 2002;58(11):1587\u20138.","journal-title":"Neurology"},{"issue":"6","key":"1900_CR9","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/ana.10040","volume":"50","author":"R Natte","year":"2001","unstructured":"Natte R, et al. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann Neurol. 2001;50(6):765\u201372.","journal-title":"Ann Neurol"},{"key":"1900_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jocn.2018.10.034","volume":"59","author":"MH Ahmad","year":"2019","unstructured":"Ahmad MH, Fatima M, Mondal AC. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer's disease: rational insights for the therapeutic approaches. J Clin Neurosci. 2019;59:6\u201311.","journal-title":"J Clin Neurosci"},{"issue":"2","key":"1900_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s11481-008-9142-2","volume":"4","author":"S Venneti","year":"2009","unstructured":"Venneti S, Wiley CA, Kofler J. Imaging microglial activation during neuroinflammation and Alzheimer's disease. J NeuroImmune Pharmacol. 2009;4(2):227\u201343.","journal-title":"J NeuroImmune Pharmacol"},{"issue":"11","key":"1900_CR12","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/nn1997","volume":"10","author":"UK Hanisch","year":"2007","unstructured":"Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007;10(11):1387\u201394.","journal-title":"Nat Neurosci"},{"issue":"7","key":"1900_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14(7):463\u201377.","journal-title":"Nat Rev Immunol"},{"issue":"6116","key":"1900_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1126\/science.1227901","volume":"339","author":"A Aguzzi","year":"2013","unstructured":"Aguzzi A, Barres BA, Bennett ML. Microglia: scapegoat, saboteur, or something else? Science. 2013;339(6116):156\u201361.","journal-title":"Science"},{"issue":"3","key":"1900_CR15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47(3):566\u2013581.e9.","journal-title":"Immunity"},{"key":"1900_CR16","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jns.2017.03.031","volume":"376","author":"E Bagyinszky","year":"2017","unstructured":"Bagyinszky E, et al. Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis. J Neurol Sci. 2017;376:242\u201354.","journal-title":"J Neurol Sci"},{"issue":"25","key":"1900_CR17","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.2174\/138161210793176572","volume":"16","author":"P Agostinho","year":"2010","unstructured":"Agostinho P, Cunha RA, Oliveira C. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Curr Pharm Des. 2010;16(25):2766\u201378.","journal-title":"Curr Pharm Des"},{"key":"1900_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.arr.2014.07.004","volume":"18","author":"E Avila-Munoz","year":"2014","unstructured":"Avila-Munoz E, Arias C. When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease. Ageing Res Rev. 2014;18:29\u201340.","journal-title":"Ageing Res Rev"},{"issue":"7638","key":"1900_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u20137.","journal-title":"Nature"},{"issue":"6","key":"1900_CR20","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.neuron.2018.10.031","volume":"100","author":"A Litvinchuk","year":"2018","unstructured":"Litvinchuk A, et al. Complement C3aR inactivation attenuates tau pathology and reverses an immune network deregulated in tauopathy models and Alzheimer's disease. Neuron. 2018;100(6):1337\u201353 e5.","journal-title":"Neuron"},{"issue":"7","key":"1900_CR21","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","volume":"24","author":"SP Yun","year":"2018","unstructured":"Yun SP, et al. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease. Nat Med. 2018;24(7):931\u20138.","journal-title":"Nat Med"},{"issue":"1","key":"1900_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40478-019-0735-1","volume":"7","author":"K Hartmann","year":"2019","unstructured":"Hartmann K, et al. Complement 3(+)-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia. Acta Neuropathol Commun. 2019;7(1):83.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1900_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"CM Karch","year":"2015","unstructured":"Karch CM, Goate AM. Alzheimer's disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry. 2015;77(1):43\u201351.","journal-title":"Biol Psychiatry"},{"key":"1900_CR24","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2147\/CIA.S105769","volume":"11","author":"M Giri","year":"2016","unstructured":"Giri M, Zhang M, Lu Y. Genes associated with Alzheimer's disease: an overview and current status. Clin Interv Aging. 2016;11:665\u201381.","journal-title":"Clin Interv Aging"},{"issue":"9","key":"1900_CR25","doi-asserted-by":"publisher","first-page":"e1004606","DOI":"10.1371\/journal.pgen.1004606","volume":"10","author":"GW Beecham","year":"2014","unstructured":"Beecham GW, et al. Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. PLoS Genet. 2014;10(9):e1004606.","journal-title":"PLoS Genet"},{"issue":"10","key":"1900_CR26","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/glia.22988","volume":"64","author":"PD Wes","year":"2016","unstructured":"Wes PD, et al. Targeting microglia for the treatment of Alzheimer's Disease. Glia. 2016;64(10):1710\u201332.","journal-title":"Glia"},{"issue":"9","key":"1900_CR27","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nn1302","volume":"7","author":"MC Herzig","year":"2004","unstructured":"Herzig MC, et al. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci. 2004;7(9):954\u201360.","journal-title":"Nat Neurosci"},{"issue":"7","key":"1900_CR28","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1161\/01.STR.27.7.1155","volume":"27","author":"M Yamada","year":"1996","unstructured":"Yamada M, et al. Immune reactions associated with cerebral amyloid angiopathy. Stroke. 1996;27(7):1155\u201362.","journal-title":"Stroke"},{"issue":"1","key":"1900_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s004010051186","volume":"100","author":"R Vidal","year":"2000","unstructured":"Vidal R, et al. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele. Acta Neuropathol. 2000;100(1):1\u201312.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"1900_CR30","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell. 2015;160(6):1061\u201371.","journal-title":"Cell"},{"issue":"5","key":"1900_CR31","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang Y, et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J Exp Med. 2016;213(5):667\u201375.","journal-title":"J Exp Med"},{"issue":"4","key":"1900_CR32","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan P, et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016;90(4):724\u201339.","journal-title":"Neuron"},{"issue":"4","key":"1900_CR33","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland TK, et al. TREM2 maintains microglial metabolic fitness in Alzheimer's disease. Cell. 2017;170(4):649\u2013663.e13.","journal-title":"Cell"},{"issue":"3","key":"1900_CR34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.20142322","volume":"212","author":"TR Jay","year":"2015","unstructured":"Jay TR, et al. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. J Exp Med. 2015;212(3):287\u201395.","journal-title":"J Exp Med"},{"issue":"2-3","key":"1900_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00429-009-0221-9","volume":"214","author":"HJ Garringer","year":"2010","unstructured":"Garringer HJ, et al. Modeling familial British and Danish dementia. Brain Struct Funct. 2010;214(2-3):235\u201344.","journal-title":"Brain Struct Funct"},{"issue":"3","key":"1900_CR36","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/jnen\/61.3.254","volume":"61","author":"JL Holton","year":"2002","unstructured":"Holton JL, et al. Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta. J Neuropathol Exp Neurol. 2002;61(3):254\u201367.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"1900_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1750-3639.2008.00164.x","volume":"19","author":"R Vidal","year":"2009","unstructured":"Vidal R, et al. Cerebral amyloid angiopathy and parenchymal amyloid deposition in transgenic mice expressing the Danish mutant form of human BRI2. Brain Pathol. 2009;19(1):58\u201368.","journal-title":"Brain Pathol"},{"issue":"1","key":"1900_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40478-019-0680-z","volume":"7","author":"Y You","year":"2019","unstructured":"You Y, et al. Tau as a mediator of neurotoxicity associated to cerebral amyloid angiopathy. Acta Neuropathol Commun. 2019;7(1):26.","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"1900_CR39","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1523\/JNEUROSCI.3516-14.2015","volume":"35","author":"L Ben Haim","year":"2015","unstructured":"Ben Haim L, et al. The JAK\/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer&#039;s and Huntington&#039;s diseases. J Neurosci. 2015;35(6):2817.","journal-title":"J Neurosci"},{"issue":"1","key":"1900_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13024-017-0216-6","volume":"12","author":"SM Bemiller","year":"2017","unstructured":"Bemiller SM, et al. TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy. Mol Neurodegener. 2017;12(1):74.","journal-title":"Mol Neurodegener"},{"key":"1900_CR41","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.mex.2018.05.011","volume":"5","author":"LS Toni","year":"2018","unstructured":"Toni LS, et al. Optimization of phenol-chloroform RNA extraction. MethodsX. 2018;5:599\u2013608.","journal-title":"MethodsX"},{"issue":"1","key":"1900_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"4","key":"1900_CR43","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/bioinformatics\/bts731","volume":"29","author":"MR Breese","year":"2013","unstructured":"Breese MR, Liu Y. NGSUtils: a software suite for analyzing and manipulating next-generation sequencing datasets. Bioinformatics. 2013;29(4):494\u20136.","journal-title":"Bioinformatics"},{"issue":"7","key":"1900_CR44","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923\u201330.","journal-title":"Bioinformatics"},{"issue":"19","key":"1900_CR45","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels P, et al. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 2016;32(19):3047\u20138.","journal-title":"Bioinformatics"},{"issue":"1","key":"1900_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340.","journal-title":"Bioinformatics"},{"issue":"10","key":"1900_CR47","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy DJ, Chen Y, Smyth GK. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012;40(10):4288\u201397.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1900_CR48","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1517\/14728222.2016.1135132","volume":"20","author":"RJ Hodes","year":"2016","unstructured":"Hodes RJ, Buckholtz N. Accelerating Medicines Partnership: Alzheimer's Disease (AMP-AD) knowledge portal aids Alzheimer's drug discovery through open data sharing. Expert Opin Ther Targets. 2016;20(4):389\u201391.","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"1900_CR49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2217\/nmt-2017-0008","volume":"7","author":"N Ertekin-Taner","year":"2017","unstructured":"Ertekin-Taner N. Identifying therapeutic targets for Alzheimer's disease with big data. Neurodegener Dis Manag. 2017;7(2):101\u20135.","journal-title":"Neurodegener Dis Manag"},{"issue":"3","key":"1900_CR50","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.bbadis.2015.11.014","volume":"1862","author":"M Pekny","year":"2016","unstructured":"Pekny M, Pekna M. Reactive gliosis in the pathogenesis of CNS diseases. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2016;1862(3):483\u201391.","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"1","key":"1900_CR51","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4172\/2155-9899.1000188","volume":"5","author":"CR Formichella","year":"2014","unstructured":"Formichella CR, et al. Astrocyte reactivity: a biomarker for retinal ganglion cell health in retinal neurodegeneration. J Clin Cell Immunol. 2014;5(1):188.","journal-title":"J Clin Cell Immunol"},{"key":"1900_CR52","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fnins.2017.00318","volume":"11","author":"FD Echevarria","year":"2017","unstructured":"Echevarria FD, Formichella CR, Sappington RM. Interleukin-6 deficiency attenuates retinal ganglion cell axonopathy and glaucoma-related vision loss. Front Neurosci. 2017;11:318.","journal-title":"Front Neurosci"},{"key":"1900_CR53","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jchemneu.2018.06.001","volume":"92","author":"LCD Smyth","year":"2018","unstructured":"Smyth LCD, et al. Markers for human brain pericytes and smooth muscle cells. J Chem Neuroanat. 2018;92:48\u201360.","journal-title":"J Chem Neuroanat"},{"key":"1900_CR54","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fncel.2017.00235","volume":"11","author":"MDM Fernandez-Arjona","year":"2017","unstructured":"Fernandez-Arjona MDM, et al. Microglia morphological categorization in a rat model of neuroinflammation by hierarchical cluster and principal components analysis. Front Cell Neurosci. 2017;11:235.","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"1900_CR55","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414\u201330.","journal-title":"Nat Genet"},{"issue":"1","key":"1900_CR56","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-017-0184-x","volume":"12","author":"AG Efthymiou","year":"2017","unstructured":"Efthymiou AG, Goate AM. Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk. Mol Neurodegener. 2017;12(1):43.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"1900_CR57","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, et al. Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med. 2013;368(2):107\u201316.","journal-title":"N Engl J Med"},{"issue":"5","key":"1900_CR58","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ng.3246","volume":"47","author":"S Steinberg","year":"2015","unstructured":"Steinberg S, et al. Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease. Nat Genet. 2015;47(5):445\u20137.","journal-title":"Nat Genet"},{"issue":"1","key":"1900_CR59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/ejhg.2009.134","volume":"18","author":"C Xie","year":"2010","unstructured":"Xie C, et al. The common biological basis for common complex diseases: evidence from lipoprotein lipase gene. Eur J Hum Genet. 2010;18(1):3\u20137.","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"1900_CR60","doi-asserted-by":"publisher","first-page":"940","DOI":"10.4088\/JCP.v66n0720","volume":"66","author":"A Papassotiropoulos","year":"2005","unstructured":"Papassotiropoulos A, et al. A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. J Clin Psychiatry. 2005;66(7):940\u20137.","journal-title":"J Clin Psychiatry"},{"issue":"1-2","key":"1900_CR61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0006-8993(03)02867-1","volume":"979","author":"T Mizuno","year":"2003","unstructured":"Mizuno T, et al. Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res. 2003;979(1-2):65\u201370.","journal-title":"Brain Res"},{"key":"1900_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-2094-8-9","volume":"8","author":"MM Pabon","year":"2011","unstructured":"Pabon MM, et al. CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease. J Neuroinflammation. 2011;8:9.","journal-title":"J Neuroinflammation"},{"key":"1900_CR63","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12974-015-0386-5","volume":"12","author":"HY Febinger","year":"2015","unstructured":"Febinger HY, et al. Time-dependent effects of CX3CR1 in a mouse model of mild traumatic brain injury. J Neuroinflammation. 2015;12:154.","journal-title":"J Neuroinflammation"},{"key":"1900_CR64","first-page":"8090918","volume":"2016","author":"P Chen","year":"2016","unstructured":"Chen P, et al. CX3CL1\/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection. Biomed Res Int. 2016;2016:8090918.","journal-title":"Biomed Res Int"},{"issue":"2","key":"1900_CR65","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.semcdb.2005.01.005","volume":"16","author":"JE Vance","year":"2005","unstructured":"Vance JE, Hayashi H, Karten B. Cholesterol homeostasis in neurons and glial cells. Semin Cell Dev Biol. 2005;16(2):193\u2013212.","journal-title":"Semin Cell Dev Biol"},{"issue":"8","key":"1900_CR66","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/jnen\/60.8.778","volume":"60","author":"T Mori","year":"2001","unstructured":"Mori T, et al. Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APP(SW) mice. J Neuropathol Exp Neurol. 2001;60(8):778\u201385.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1900_CR67","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/B978-0-12-386487-1.00017-1","volume":"108","author":"FR Maxfield","year":"2012","unstructured":"Maxfield FR, W\u00fcstner D. Analysis of cholesterol trafficking with fluorescent probes. Methods Cell Biol. 2012;108:367\u201393.","journal-title":"Methods Cell Biol"},{"issue":"1","key":"1900_CR68","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12916-019-1299-4","volume":"17","author":"M Safieh","year":"2019","unstructured":"Safieh M, Korczyn AD, Michaelson DM. ApoE4: an emerging therapeutic target for Alzheimer\u2019s disease. BMC Med. 2019;17(1):64.","journal-title":"BMC Med"},{"issue":"6","key":"1900_CR69","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jalz.2014.06.015","volume":"10","author":"DM Michaelson","year":"2014","unstructured":"Michaelson DM. APOE epsilon4: the most prevalent yet understudied risk factor for Alzheimer's disease. Alzheimers Dement. 2014;10(6):861\u20138.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1900_CR70","doi-asserted-by":"publisher","first-page":"a006312","DOI":"10.1101\/cshperspect.a006312","volume":"2","author":"DM Holtzman","year":"2012","unstructured":"Holtzman DM, Herz J, Bu G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(3):a006312.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"11","key":"1900_CR71","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.2174\/1567205013666160401115127","volume":"13","author":"AM Di Battista","year":"2016","unstructured":"Di Battista AM, Heinsinger NM, Rebeck GW. Alzheimer\u2019s disease genetic risk factor APOE-epsilon4 also affects normal brain function. Curr Alzheimer Res. 2016;13(11):1200\u20137.","journal-title":"Curr Alzheimer Res"},{"issue":"24","key":"1900_CR72","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.3390\/ijms20246319","volume":"20","author":"P Cisternas","year":"2019","unstructured":"Cisternas P, Taylor X, Lasagna-Reeves CA. The amyloid-tau-neuroinflammation axis in the context of cerebral amyloid angiopathy. Int J Mol Sci. 2019;20(24):6319.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1900_CR73","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13024-017-0197-5","volume":"12","author":"TR Jay","year":"2017","unstructured":"Jay TR, von Saucken VE, Landreth GE. TREM2 in neurodegenerative diseases. Mol Neurodegener. 2017;12(1):56.","journal-title":"Mol Neurodegener"},{"issue":"43","key":"1900_CR74","doi-asserted-by":"publisher","first-page":"11524","DOI":"10.1073\/pnas.1710311114","volume":"114","author":"CEG Leyns","year":"2017","unstructured":"Leyns CEG, et al. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. Proc Natl Acad Sci U S A. 2017;114(43):11524\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1900_CR75","doi-asserted-by":"publisher","first-page":"664","DOI":"10.14336\/AD.2018.0720","volume":"10","author":"K Li","year":"2019","unstructured":"Li K, et al. Reactive astrocytes in neurodegenerative diseases. Aging Dis. 2019;10(3):664\u201375.","journal-title":"Aging Dis"},{"issue":"4","key":"1900_CR76","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/bpa.12005","volume":"23","author":"M Zabel","year":"2013","unstructured":"Zabel M, et al. A shift in microglial beta-amyloid binding in Alzheimer's disease is associated with cerebral amyloid angiopathy. Brain Pathol. 2013;23(4):390\u2013401.","journal-title":"Brain Pathol"},{"issue":"3","key":"1900_CR77","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00401-011-0834-y","volume":"122","author":"M Merlini","year":"2011","unstructured":"Merlini M, et al. Vascular beta-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAbeta mice. Acta Neuropathol. 2011;122(3):293\u2013311.","journal-title":"Acta Neuropathol"},{"issue":"10","key":"1900_CR78","first-page":"136","volume":"3","author":"WY Wang","year":"2015","unstructured":"Wang WY, et al. Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann Transl Med. 2015;3(10):136.","journal-title":"Ann Transl Med"},{"issue":"4","key":"1900_CR79","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/cen3.12475","volume":"9","author":"T Saito","year":"2018","unstructured":"Saito T, Saido TC. Neuroinflammation in mouse models of Alzheimer\u2019s disease. Clin Exp Neuroimmunol. 2018;9(4):211\u20138.","journal-title":"Clin Exp Neuroimmunol"},{"issue":"6","key":"1900_CR80","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/NEN.0b013e3182933788","volume":"72","author":"A Serrano-Pozo","year":"2013","unstructured":"Serrano-Pozo A, et al. Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease. J Neuropathol Exp Neurol. 2013;72(6):462\u201371.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"1900_CR81","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13024-017-0231-7","volume":"12","author":"JL Jankowsky","year":"2017","unstructured":"Jankowsky JL, Zheng H. Practical considerations for choosing a mouse model of Alzheimer's disease. Mol Neurodegener. 2017;12(1):89.","journal-title":"Mol Neurodegener"},{"key":"1900_CR82","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fncel.2018.00193","volume":"12","author":"C-Y Liu","year":"2018","unstructured":"Liu C-Y, et al. Emerging roles of astrocytes in neuro-vascular unit and the tripartite synapse with emphasis on reactive gliosis in the context of Alzheimer's disease. Front Cell Neurosci. 2018;12:193.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"1900_CR83","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","volume":"119","author":"MV Sofroniew","year":"2010","unstructured":"Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119(1):7\u201335.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"1900_CR84","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrn3484","volume":"14","author":"LE Clarke","year":"2013","unstructured":"Clarke LE, Barres BA. Emerging roles of astrocytes in neural circuit development. Nat Rev Neurosci. 2013;14(5):311\u201321.","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"1900_CR85","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/ijms20020282","volume":"20","author":"L Huang","year":"2019","unstructured":"Huang L, et al. Astrocyte signaling in the neurovascular unit after central nervous system injury. Int J Mol Sci. 2019;20(2):282.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1900_CR86","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","volume":"46","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Barres BA. Reactive astrocytes: production, function, and therapeutic potential. Immunity. 2017;46(6):957\u201367.","journal-title":"Immunity"},{"issue":"1","key":"1900_CR87","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4049\/jimmunol.142.1.100","volume":"142","author":"SJ Warner","year":"1989","unstructured":"Warner SJ, Libby P. Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. J Immunol. 1989;142(1):100\u20139.","journal-title":"J Immunol"},{"issue":"4","key":"1900_CR88","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1089\/107999001750169871","volume":"21","author":"L Chi","year":"2001","unstructured":"Chi L, et al. Interleukin-6 production by endothelial cells via stimulation of protease-activated receptors is amplified by endotoxin and tumor necrosis factor-alpha. J Interf Cytokine Res. 2001;21(4):231\u201340.","journal-title":"J Interf Cytokine Res"},{"issue":"3","key":"1900_CR89","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen IE, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk. Nat Genet. 2019;51(3):404\u201313.","journal-title":"Nat Genet"},{"issue":"2","key":"1900_CR90","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12264-016-0011-3","volume":"32","author":"L Shen","year":"2016","unstructured":"Shen L, Jia J. An overview of genome-wide association studies in Alzheimer\u2019s disease. Neurosci Bull. 2016;32(2):183\u201390.","journal-title":"Neurosci Bull"},{"issue":"1","key":"1900_CR91","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1212\/NXG.0000000000000211","volume":"4","author":"M Makela","year":"2018","unstructured":"Makela M, et al. Alzheimer risk loci and associated neuropathology in a population-based study (Vantaa 85+). Neurol Genet. 2018;4(1):e211.","journal-title":"Neurol Genet"},{"key":"1900_CR92","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1749-6632.2012.06513.x","volume":"1259","author":"P Gamba","year":"2012","unstructured":"Gamba P, et al. The link between altered cholesterol metabolism and Alzheimer's disease. Ann N Y Acad Sci. 2012;1259:54\u201364.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1900_CR93","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","volume":"63","author":"J Kim","year":"2009","unstructured":"Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer's disease. Neuron. 2009;63(3):287\u2013303.","journal-title":"Neuron"},{"issue":"7","key":"1900_CR94","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nm1058","volume":"10","author":"M Koistinaho","year":"2004","unstructured":"Koistinaho M, et al. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med. 2004;10(7):719\u201326.","journal-title":"Nat Med"},{"issue":"1","key":"1900_CR95","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","volume":"541","author":"Y Namba","year":"1991","unstructured":"Namba Y, et al. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 1991;541(1):163\u20136.","journal-title":"Brain Res"},{"issue":"2","key":"1900_CR96","first-page":"238","volume":"147","author":"T Wisniewski","year":"1995","unstructured":"Wisniewski T, et al. Conformational mimicry in Alzheimer\u2019s disease. Role of apolipoproteins in amyloidogenesis. Am J Pathol. 1995;147(2):238\u201344.","journal-title":"Am J Pathol"},{"issue":"5","key":"1900_CR97","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90(5):1977\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1900_CR98","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/ana.410380219","volume":"38","author":"SM Greenberg","year":"1995","unstructured":"Greenberg SM, et al. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol. 1995;38(2):254\u20139.","journal-title":"Ann Neurol"},{"issue":"1","key":"1900_CR99","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1212\/WNL.47.1.190","volume":"47","author":"JM Olichney","year":"1996","unstructured":"Olichney JM, et al. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer\u2019s disease and Lewy body variant. Neurology. 1996;47(1):190\u20136.","journal-title":"Neurology"},{"issue":"2","key":"1900_CR100","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0694-180","volume":"7","author":"EH Corder","year":"1994","unstructured":"Corder EH, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7(2):180\u20134.","journal-title":"Nat Genet"},{"issue":"11","key":"1900_CR101","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1523\/JNEUROSCI.5170-04.2005","volume":"25","author":"JD Fryer","year":"2005","unstructured":"Fryer JD, et al. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. J Neurosci. 2005;25(11):2803\u201310.","journal-title":"J Neurosci"},{"key":"1900_CR102","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40478-015-0250-y","volume":"3","author":"F Liao","year":"2015","unstructured":"Liao F, et al. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models. Acta Neuropathol Commun. 2015;3:70.","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"1900_CR103","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41591-020-0886-4","volume":"26","author":"JW Blanchard","year":"2020","unstructured":"Blanchard JW, et al. Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes. Nat Med. 2020;26(6):952\u201363.","journal-title":"Nat Med"},{"issue":"2","key":"1900_CR104","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuron.2017.02.042","volume":"94","author":"JD Ulrich","year":"2017","unstructured":"Ulrich JD, et al. Elucidating the Role of TREM2 in Alzheimer\u2019s Disease. Neuron. 2017;94(2):237\u201348.","journal-title":"Neuron"},{"issue":"6","key":"1900_CR105","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nri1106","volume":"3","author":"M Colonna","year":"2003","unstructured":"Colonna M. TREMs in the immune system and beyond. Nat Rev Immunol. 2003;3(6):445\u201353.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"1900_CR106","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","volume":"105","author":"AA Nugent","year":"2020","unstructured":"Nugent AA, et al. TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge. Neuron. 2020;105(5):837\u201354 e9.","journal-title":"Neuron"},{"issue":"2","key":"1900_CR107","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh FL, et al. TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron. 2016;91(2):328\u201340.","journal-title":"Neuron"},{"issue":"1","key":"1900_CR108","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12974-020-01755-y","volume":"17","author":"X Zhu","year":"2020","unstructured":"Zhu X, et al. Robust neuroinflammation and perivascular pathology in rTg-DI rats, a novel model of microvascular cerebral amyloid angiopathy. J Neuroinflammation. 2020;17(1):78.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1900_CR109","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","volume":"165","author":"Y Liu","year":"2016","unstructured":"Liu Y, Beyer A, Aebersold R. On the dependency of cellular protein levels on mRNA abundance. Cell. 2016;165(3):535\u201350.","journal-title":"Cell"},{"issue":"1","key":"1900_CR110","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3233\/JAD-160663","volume":"55","author":"AA Raha","year":"2017","unstructured":"Raha AA, et al. Neuroprotective effect of TREM-2 in aging and Alzheimer's disease model. J Alzheimers Dis. 2017;55(1):199\u2013217.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1900_CR111","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrneurol.2014.207","volume":"11","author":"X Hu","year":"2015","unstructured":"Hu X, et al. Microglial and macrophage polarization-new prospects for brain repair. Nat Rev Neurol. 2015;11(1):56\u201364.","journal-title":"Nat Rev Neurol"},{"key":"1900_CR112","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.pneurobio.2016.01.005","volume":"157","author":"Y Ma","year":"2017","unstructured":"Ma Y, et al. The biphasic function of microglia in ischemic stroke. Prog Neurobiol. 2017;157:247\u201372.","journal-title":"Prog Neurobiol"},{"issue":"1","key":"1900_CR113","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12974-018-1189-2","volume":"15","author":"C Xing","year":"2018","unstructured":"Xing C, et al. A potential gliovascular mechanism for microglial activation: differential phenotypic switching of microglia by endothelium versus astrocytes. J Neuroinflammation. 2018;15(1):143.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1900_CR114","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/1073858418783959","volume":"25","author":"MK Jha","year":"2019","unstructured":"Jha MK, et al. Microglia-astrocyte crosstalk: an intimate molecular conversation. Neuroscientist. 2019;25(3):227\u201340.","journal-title":"Neuroscientist"},{"issue":"6","key":"1900_CR115","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.bbamcr.2008.11.009","volume":"1793","author":"R Donato","year":"2009","unstructured":"Donato R, et al. S100B\u2019s double life: intracellular regulator and extracellular signal. Biochim Biophys Acta. 2009;1793(6):1008\u201322.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"1900_CR116","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1750-3639.1998.tb00168.x","volume":"8","author":"NP Hailer","year":"1998","unstructured":"Hailer NP, et al. Astrocytic factors deactivate antigen presenting cells that invade the central nervous system. Brain Pathol. 1998;8(3):459\u201374.","journal-title":"Brain Pathol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-020-01900-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-020-01900-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-020-01900-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T20:41:29Z","timestamp":1696452089000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-020-01900-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,25]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1900"],"URL":"https:\/\/doi.org\/10.1186\/s12974-020-01900-7","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,25]]},"assertion":[{"value":"13 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments conformed to the National Academy of Sciences Guide for Care and Use of Laboratory Animals and were approved by the Indiana University School of Medicine (IUSM) Animal Care and Use Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"223"}}